369 related articles for article (PubMed ID: 19371331)
1. cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies.
Zaccolo M
Br J Pharmacol; 2009 Sep; 158(1):50-60. PubMed ID: 19371331
[TBL] [Abstract][Full Text] [Related]
2. Compartmentation of cAMP signalling in cardiomyocytes in health and disease.
Perera RK; Nikolaev VO
Acta Physiol (Oxf); 2013 Apr; 207(4):650-62. PubMed ID: 23383621
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cardiac function by cAMP nanodomains.
Folkmanaite M; Zaccolo M
Biosci Rep; 2023 Feb; 43(2):. PubMed ID: 36749130
[TBL] [Abstract][Full Text] [Related]
4. Resolution of cAMP signals in three-dimensional microdomains using novel, real-time sensors.
Karpen JW; Rich TC
Proc West Pharmacol Soc; 2004; 47():1-5. PubMed ID: 15633600
[TBL] [Abstract][Full Text] [Related]
5. Compartmentalized cAMP signalling and control of cardiac rhythm.
Tomek J; Zaccolo M
Philos Trans R Soc Lond B Biol Sci; 2023 Jun; 378(1879):20220172. PubMed ID: 37122225
[TBL] [Abstract][Full Text] [Related]
6. Spatial and temporal aspects of cAMP signalling in cardiac myocytes.
Iancu RV; Ramamurthy G; Harvey RD
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1343-8. PubMed ID: 18671712
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in cardiac beta(2)-adrenergic signal transduction.
Xiao RP; Cheng H; Zhou YY; Kuschel M; Lakatta EG
Circ Res; 1999 Nov; 85(11):1092-100. PubMed ID: 10571541
[TBL] [Abstract][Full Text] [Related]
8. Functional localization of cAMP signalling in cardiac myocytes.
Vandecasteele G; Rochais F; Abi-Gerges A; Fischmeister R
Biochem Soc Trans; 2006 Aug; 34(Pt 4):484-8. PubMed ID: 16856839
[TBL] [Abstract][Full Text] [Related]
9. Spatial control of cAMP signalling in health and disease.
Zaccolo M
Curr Opin Pharmacol; 2011 Dec; 11(6):649-55. PubMed ID: 22000603
[TBL] [Abstract][Full Text] [Related]
10. cAMP: novel concepts in compartmentalised signalling.
Edwards HV; Christian F; Baillie GS
Semin Cell Dev Biol; 2012 Apr; 23(2):181-90. PubMed ID: 21930230
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes.
Belhassen L; Kelly RA; Smith TW; Balligand JL
J Clin Invest; 1996 Apr; 97(8):1908-15. PubMed ID: 8621775
[TBL] [Abstract][Full Text] [Related]
12. cGMP-cAMP interplay in cardiac myocytes: a local affair with far-reaching consequences for heart function.
Stangherlin A; Zaccolo M
Biochem Soc Trans; 2012 Feb; 40(1):11-4. PubMed ID: 22260658
[TBL] [Abstract][Full Text] [Related]
13. Compartmentation of G protein-coupled signaling pathways in cardiac myocytes.
Steinberg SF; Brunton LL
Annu Rev Pharmacol Toxicol; 2001; 41():751-73. PubMed ID: 11264475
[TBL] [Abstract][Full Text] [Related]
14. The Epac1 Protein: Pharmacological Modulators, Cardiac Signalosome and Pathophysiology.
Bouvet M; Blondeau JP; Lezoualc'h F
Cells; 2019 Nov; 8(12):. PubMed ID: 31795450
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
16. Cyclic nucleotide phosphodiesterases in heart and vessels: A therapeutic perspective.
Bobin P; Belacel-Ouari M; Bedioune I; Zhang L; Leroy J; Leblais V; Fischmeister R; Vandecasteele G
Arch Cardiovasc Dis; 2016; 109(6-7):431-43. PubMed ID: 27184830
[TBL] [Abstract][Full Text] [Related]
17. Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy.
Movsesian MA; Bristow MR
Curr Top Dev Biol; 2005; 68():25-48. PubMed ID: 16124995
[TBL] [Abstract][Full Text] [Related]
18. Heart failure leads to altered β2-adrenoceptor/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman/Na,K ATPase microdomain.
Bastug-Özel Z; Wright PT; Kraft AE; Pavlovic D; Howie J; Froese A; Fuller W; Gorelik J; Shattock MJ; Nikolaev VO
Cardiovasc Res; 2019 Mar; 115(3):546-555. PubMed ID: 30165515
[TBL] [Abstract][Full Text] [Related]
19. Imaging cAMP nanodomains in the heart.
Chao YC; Surdo NC; Pantano S; Zaccolo M
Biochem Soc Trans; 2019 Oct; 47(5):1383-1392. PubMed ID: 31670375
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 Axis.
Aoyama M; Kawase H; Bando YK; Monji A; Murohara T
Circ Heart Fail; 2016 Jan; 9(1):e002081. PubMed ID: 26721911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
